ニコラ・ブーチェビッチ Nikola Vučević Nikola Vučević
21
51 G
15.9
PPG5.5
RPG4.8
APG0.6
SPG0.4
BPG0.7
FG%45.0
3P%37.5
FT%52.9
206cm/120kgThe country the NBA has on file. It need not match where they were born or whom they play for.Read in the glossaryHow they entered the league: which round and overall pick, or that they went undrafted.Read in the glossary
| Year | Team | POS | Age | G | MP | Shooting | On-ball | Off-ball | Rebounds | Defense | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Scoring | 2P | 3P | FT | AST | Hub | Drive | Care | Cut | Screen | REB | Conv | BOX | 1on1 | Rim | Hustle | ||||||
| 2011-12 | PHI | C/F | 21 | 51 | 15.9 | D | D | — | E | E | A | ||||||||||
| 2012-13 | ORL | C | 22 | 77 | 33.2 | C | B | — | E | D | F | B | S | ||||||||
| 2013-14 | ORL | C | 23 | 57 | 31.8 | C | C | — | C | D | E | — | C | A | A | A | |||||
| 2014-15 | ORL | C | 24 | 74 | 34.2 | A | A | — | D | D | C | D | E | B | A | S | |||||
| 2015-16 | ORL | C | 25 | 65 | 31.3 | B | A | — | D | C | C | C | D | D | B | A | |||||
| 2016-17 | ORL | C | 26 | 75 | 28.8 | B | B | D | E | C | E | D | B | B | B | A | S | C | |||
| 2017-18 | ORL | C | 27 | 57 | 29.5 | B | B | E | C | C | D | E | C | E | B | B | S | B | D | B | E |
| 2018-19 | ORL | C | 28 | 80 | 31.4 | A | A | C | C | B | C | C | C | B | A | A | A | A | F | A | F |
| 2019-20 | ORL | C | 29 | 62 | 32.2 | B | B | D | C | C | — | C | A | B | A | A | S | B | F | B | F |
| 2020-21 | ORL/CHI | C | 30 | 70 | 33.5 | A | B | A | B | B | G | C | B | C | B | A | S | B | G | B | E |
| 2021-22 | CHI | C | 31 | 73 | 33.1 | B | B | E | D | C | D | F | C | C | A | A | A | B | E | C | E |
| 2022-23 | CHI | C | 32 | 82 | 33.5 | B | A | D | B | C | E | D | B | B | B | A | A | B | D | C | E |
| 2023-24 | CHI | C | 33 | 76 | 34.3 | B | B | G | C | C | E | E | B | C | B | B | A | B | E | C | E |
| 2024-25 | CHI | C | 34 | 73 | 31.2 | B | A | B | C | C | D | D | B | B | B | B | S | B | D | C | F |
| 2025-26 | CHI/BOS | C | 35 | 64 | 28.4 | B | B | C | C | C | E | F | A | B | B | B | S | A | E | C | E |
131 / 291(45.0%)
ColorZone FG% − league average (points)+7 or better+2.5−2.5−7−7 or worse
HatchingToo few shots to measure
SizeShots taken from that cell
| Zone | Att | Made | FG% | League | Diff |
|---|---|---|---|---|---|
| Rim | 112 | 68 | 60.7% | 60.5% | +0.2 |
| Paint · Center | 51 | 16 | 31.4% | 37.4% | −6.1 |
| Mid-range · Left | 35 | 12 | 34.3% | 37.9% | −3.6 |
| Mid-range · Right | 28 | 12 | 42.9% | 38.2% | +4.6 |
| Mid-range · Center | 19 | 4 | 21.1% | 43.8% | −22.7 |
| Mid-range · Left wing | 18 | 7 | 38.9% | 38.9% | −0.0 |
| Mid-range · Right wing | 12 | 4 | 33.3% | 37.7% | −4.3 |
| Paint · Right | 6 | 4 | 66.7% | 38.7% | +28.0 |
| Above the break 3 · Center | 3 | 0 | 0.0% | 33.2% | −33.2 |
| Above the break 3 · Left wing | 3 | 2 | 66.7% | 34.0% | +32.6 |
| Paint · Left | 2 | 1 | 50.0% | 40.1% | +9.9 |
| Left corner 3 · Left | 2 | 1 | 50.0% | 37.6% | +12.4 |
Each hexagon is about two feet across. Size is how many shots came from that cell, color is the gap to the league average (shrunk toward that zone's FG% before comparing). Hatched cells have too few shots to measure; free throws carry no coordinates, so they are left out. Zones with fewer than 10 attempts are left uncolored. The NBA only publishes shot coordinates from 1996-97 on.
| Year | Team | POS | Age | G | GS | MP | FG | FGA | FG% | 2P | 2PA | 2P% | 3P | 3PA | 3P% | FT | FTA | FT% | ORB | DRB | TRB | AST | STL | BLK | TOV | PF | PTS | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2011-12 | PHI | C/F | 21 | 51 | 15 | 15.9 | 2.6 | 5.7 | 45.0 | 2.5 | 5.5 | 45.2 | 0.1 | 0.2 | 37.5 | 0.4 | 0.7 | 52.9 | 1.7 | 3.1 | 4.8 | 0.6 | 0.4 | 0.7 | 0.6 | 2.2 | 5.5 | |
| 2012-13 | ORL | C | 22 | 77 | 77 | 33.2 | 6.0 | 11.5 | 51.9 | 6.0 | 11.5 | 52.0 | 0.0 | 0.0 | 0.0 | 1.1 | 1.6 | 68.3 | 3.5 | 8.4 | 11.9 | 1.9 | 0.8 | 1.0 | 1.8 | 2.8 | 13.1 | |
| 2013-14 | ORL | C | 23 | 57 | 57 | 31.8 | 6.2 | 12.2 | 50.7 | 6.2 | 12.2 | 50.7 | 0.0 | 0.0 | — | 1.8 | 2.4 | 76.6 | 3.2 | 7.7 | 11.0 | 1.8 | 1.1 | 0.8 | 2.0 | 3.0 | 14.2 | |
| 2014-15 | ORL | C | 24 | 74 | 74 | 34.2 | 8.5 | 16.3 | 52.3 | 8.5 | 16.2 | 52.4 | 0.0 | 0.1 | 33.3 | 2.2 | 2.9 | 75.2 | 3.2 | 7.7 | 10.9 | 2.0 | 0.7 | 0.7 | 2.0 | 3.0 | 19.3 | |
| 2015-16 | ORL | C | 25 | 65 | 60 | 31.3 | 8.2 | 16.1 | 51.0 | 8.2 | 16.0 | 51.2 | 0.0 | 0.1 | 22.2 | 1.7 | 2.3 | 75.3 | 2.7 | 6.2 | 8.9 | 2.8 | 0.8 | 1.1 | 1.9 | 2.7 | 18.2 | |
| 2016-17 | ORL | C | 26 | 75 | 55 | 28.8 | 6.4 | 13.7 | 46.8 | 6.1 | 12.7 | 48.1 | 0.3 | 1.0 | 30.7 | 1.4 | 2.1 | 66.9 | 2.3 | 8.0 | 10.4 | 2.8 | 1.0 | 1.0 | 1.6 | 2.4 | 14.6 | |
| 2017-18 | ORL | C | 27 | 57 | 57 | 29.5 | 7.0 | 14.7 | 47.5 | 5.9 | 11.2 | 52.7 | 1.1 | 3.6 | 31.4 | 1.4 | 1.6 | 81.9 | 1.8 | 7.4 | 9.2 | 3.4 | 1.0 | 1.1 | 1.9 | 2.5 | 16.5 | |
| 2018-19 | ORL | C | 28 | 80 | 80 | 31.4 | 8.8 | 16.9 | 51.8 | 7.7 | 14.0 | 54.9 | 1.1 | 2.9 | 36.4 | 2.2 | 2.8 | 78.9 | 2.8 | 9.2 | 12.0 | 3.8 | 1.0 | 1.1 | 2.0 | 2.0 | 20.8 | |
| 2019-20 | ORL | C | 29 | 62 | 62 | 32.2 | 8.0 | 16.7 | 47.7 | 6.4 | 12.0 | 53.1 | 1.6 | 4.7 | 33.9 | 2.1 | 2.7 | 78.4 | 2.3 | 8.6 | 10.9 | 3.6 | 0.9 | 0.8 | 1.4 | 2.2 | 19.6 | |
| 2020-21 | ORL/CHI | C | 30 | 70 | 70 | 33.5 | 9.5 | 19.9 | 47.7 | 7.0 | 13.7 | 51.3 | 2.5 | 6.3 | 40.0 | 1.9 | 2.2 | 84.0 | 2.1 | 9.6 | 11.7 | 3.8 | 0.9 | 0.7 | 1.8 | 2.0 | 23.4 | |
| ORL | 44 | 44 | 34.1 | 9.9 | 20.6 | 48.0 | 7.3 | 14.1 | 51.5 | 2.7 | 6.5 | 40.6 | 2.1 | 2.5 | 82.7 | 2.0 | 9.8 | 11.8 | 3.8 | 1.0 | 0.6 | 1.9 | 1.8 | 24.5 | ||||
| CHI | 26 | 26 | 32.6 | 8.8 | 18.8 | 47.1 | 6.6 | 12.9 | 50.9 | 2.3 | 5.8 | 38.8 | 1.5 | 1.8 | 87.0 | 2.3 | 9.3 | 11.5 | 3.9 | 0.9 | 0.8 | 1.7 | 2.2 | 21.5 | ||||
| 2021-22 | CHI | C | 31 | 73 | 73 | 33.1 | 7.5 | 15.8 | 47.3 | 6.1 | 11.3 | 53.7 | 1.4 | 4.5 | 31.4 | 1.3 | 1.7 | 76.0 | 1.9 | 9.1 | 11.0 | 3.2 | 1.0 | 1.0 | 1.9 | 2.5 | 17.6 | |
| 2022-23 | CHI | C | 32 | 82 | 82 | 33.5 | 7.3 | 14.0 | 52.0 | 5.8 | 9.8 | 59.4 | 1.5 | 4.2 | 34.9 | 1.6 | 1.9 | 83.5 | 1.9 | 9.1 | 11.0 | 3.2 | 0.7 | 0.7 | 1.7 | 2.2 | 17.6 | |
| 2023-24 | CHI | C | 33 | 76 | 74 | 34.3 | 7.7 | 15.9 | 48.4 | 6.5 | 11.8 | 55.0 | 1.2 | 4.1 | 29.4 | 1.4 | 1.7 | 82.2 | 2.8 | 7.8 | 10.5 | 3.3 | 0.7 | 0.8 | 1.6 | 2.5 | 18.0 | |
| 2024-25 | CHI | C | 34 | 73 | 72 | 31.2 | 7.5 | 14.2 | 53.0 | 5.8 | 9.8 | 58.7 | 1.8 | 4.4 | 40.2 | 1.6 | 2.0 | 80.5 | 2.4 | 7.6 | 10.1 | 3.5 | 0.8 | 0.7 | 1.6 | 2.2 | 18.5 | |
| 2025-26 | CHI/BOS | C | 35 | 64 | 49 | 28.4 | 6.2 | 12.5 | 49.3 | 4.6 | 8.3 | 55.7 | 1.6 | 4.2 | 36.9 | 1.2 | 1.5 | 82.8 | 2.0 | 6.4 | 8.4 | 3.3 | 0.6 | 0.6 | 1.3 | 2.0 | 15.1 | |
| CHI | 48 | 48 | 30.8 | 6.9 | 13.8 | 50.5 | 5.2 | 9.2 | 56.8 | 1.7 | 4.5 | 37.6 | 1.3 | 1.5 | 83.8 | 2.1 | 6.9 | 9.0 | 3.8 | 0.7 | 0.6 | 1.4 | 2.0 | 16.9 | ||||
| BOS | 16 | 1 | 21.1 | 3.8 | 8.7 | 43.9 | 2.7 | 5.4 | 50.0 | 1.1 | 3.3 | 34.0 | 0.9 | 1.2 | 78.9 | 1.6 | 5.1 | 6.6 | 2.0 | 0.4 | 0.6 | 1.0 | 1.9 | 9.7 |
| Year | Team | POS | Age | G | GS | MP | FG | FGA | FG% | 2P | 2PA | 2P% | 3P | 3PA | 3P% | FT | FTA | FT% | ORB | DRB | TRB | AST | STL | BLK | TOV | PF | PTS | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2011-12 | PHI | C/F | 21 | 1 | 0 | 3.0 | 0.0 | 1.0 | 0.0 | 0.0 | 1.0 | 0.0 | 0.0 | 0.0 | — | 1.0 | 2.0 | 50.0 | 0.0 | 1.0 | 1.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 1.0 | |
| 2012-13 | ORL | C | 22 | Missed the playoffs | ||||||||||||||||||||||||
| 2013-14 | ORL | C | 23 | Missed the playoffs | ||||||||||||||||||||||||
| 2014-15 | ORL | C | 24 | Missed the playoffs | ||||||||||||||||||||||||
| 2015-16 | ORL | C | 25 | Missed the playoffs | ||||||||||||||||||||||||
| 2016-17 | ORL | C | 26 | Missed the playoffs | ||||||||||||||||||||||||
| 2017-18 | ORL | C | 27 | Missed the playoffs | ||||||||||||||||||||||||
| 2018-19 | ORL | C | 28 | 5 | 5 | 29.4 | 4.2 | 11.6 | 36.2 | 3.6 | 9.0 | 40.0 | 0.6 | 2.6 | 23.1 | 2.2 | 2.8 | 78.6 | 1.8 | 6.2 | 8.0 | 3.0 | 0.4 | 1.0 | 2.6 | 2.4 | 11.2 | |
| 2019-20 | ORL | C | 29 | 5 | 5 | 37.0 | 11.2 | 22.2 | 50.5 | 7.6 | 13.4 | 56.7 | 3.6 | 8.8 | 40.9 | 2.0 | 2.2 | 90.9 | 1.8 | 9.2 | 11.0 | 4.0 | 0.8 | 0.6 | 2.6 | 2.6 | 28.0 | |
| 2020-21 | ORL/CHI | C | 30 | Missed the playoffs | ||||||||||||||||||||||||
| ORL | 44 | 44 | 34.1 | 9.9 | 20.6 | 48.0 | 7.3 | 14.1 | 51.5 | 2.7 | 6.5 | 40.6 | 2.1 | 2.5 | 82.7 | 2.0 | 9.8 | 11.8 | 3.8 | 1.0 | 0.6 | 1.9 | 1.8 | 24.5 | ||||
| CHI | 26 | 26 | 32.6 | 8.8 | 18.8 | 47.1 | 6.6 | 12.9 | 50.9 | 2.3 | 5.8 | 38.8 | 1.5 | 1.8 | 87.0 | 2.3 | 9.3 | 11.5 | 3.9 | 0.9 | 0.8 | 1.7 | 2.2 | 21.5 | ||||
| 2021-22 | CHI | C | 31 | 5 | 5 | 36.2 | 8.0 | 18.2 | 44.0 | 5.4 | 9.8 | 55.1 | 2.6 | 8.4 | 31.0 | 0.8 | 1.0 | 80.0 | 2.8 | 9.6 | 12.4 | 3.2 | 0.4 | 1.2 | 1.6 | 2.8 | 19.4 | |
| 2022-23 | CHI | C | 32 | Lost in the play-in | ||||||||||||||||||||||||
| 2023-24 | CHI | C | 33 | Lost in the play-in | ||||||||||||||||||||||||
| 2024-25 | CHI | C | 34 | Lost in the play-in | ||||||||||||||||||||||||
| 2025-26 | BOS | C | 35 | 6 | 0 | 19.0 | 2.3 | 6.2 | 37.8 | 1.2 | 2.2 | 53.8 | 1.2 | 4.0 | 29.2 | 0.3 | 0.7 | 50.0 | 0.8 | 3.5 | 4.3 | 2.3 | 0.2 | 0.5 | 1.3 | 2.5 | 6.2 | |
| Year | Team | POS | Age | G | MP | PER | TS% | eFG% | USG% | AST% | TRB% | ORB% | DRB% | TOV% | ORtg | DRtg | NetRtg | PACE | PIE | POSS | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2011-12 | PHI | C/F | 21 | 51 | 15.9 | 14.3 | 46.2 | 45.5 | 18.8 | 6.3 | 14.8 | 10.4 | 19.3 | 8.9 | 98.5 | 97.1 | 1.4 | 92.9 | 8.7 | 1,573 | |
| 2012-13 | ORL | C | 22 | 77 | 33.2 | 17.8 | 53.4 | 51.9 | 19.1 | 9.3 | 18.2 | 10.7 | 25.8 | 11.5 | 99.6 | 107.9 | -8.3 | 92.7 | 13.2 | 4,953 | |
| 2013-14 | ORL | C | 23 | 57 | 31.8 | 18.8 | 53.6 | 50.7 | 21.4 | 9.8 | 17.4 | 10.1 | 24.8 | 11.5 | 101.6 | 106.7 | -5.1 | 95.1 | 13.4 | 3,595 | |
| 2014-15 | ORL | C | 24 | 74 | 34.2 | 21.6 | 54.8 | 52.4 | 25.4 | 10.6 | 16.4 | 9.5 | 23.6 | 9.3 | 101.3 | 107.5 | -6.1 | 95.5 | 14.6 | 5,034 | |
| 2015-16 | ORL | C | 25 | 65 | 31.3 | 21.0 | 53.1 | 51.1 | 26.5 | 15.4 | 14.2 | 8.4 | 20.3 | 8.7 | 104.9 | 106.1 | -1.2 | 96.8 | 14.0 | 4,107 | |
| 2016-17 | ORL | C | 26 | 75 | 28.8 | 19.1 | 49.8 | 48.0 | 24.1 | 15.7 | 17.3 | 7.7 | 27.2 | 8.2 | 104.3 | 107.8 | -3.5 | 99.1 | 14.2 | 4,474 | |
| 2017-18 | ORL | C | 27 | 57 | 29.5 | 19.7 | 53.3 | 51.3 | 25.2 | 18.4 | 15.3 | 5.9 | 24.9 | 9.2 | 106.1 | 107.5 | -1.3 | 101.5 | 13.9 | 3,565 | |
| 2018-19 | ORL | C | 28 | 80 | 31.4 | 25.5 | 57.3 | 54.9 | 27.6 | 20.8 | 18.8 | 8.8 | 28.6 | 8.3 | 110.4 | 106.4 | 4.0 | 99.2 | 18.5 | 5,194 | |
| 2019-20 | ORL | C | 29 | 62 | 32.2 | 21.9 | 54.9 | 52.5 | 25.8 | 18.2 | 16.7 | 6.8 | 27.0 | 6.2 | 110.1 | 109.2 | 0.9 | 99.8 | 15.3 | 4,162 | |
| 2020-21 | ORL/CHI | C | 30 | 70 | 33.5 | 22.8 | 56.0 | 54.0 | 29.2 | 20.7 | 17.0 | 5.9 | 28.9 | 6.8 | 106.6 | 113.6 | -7.0 | 99.2 | 16.8 | 4,849 | |
| 2021-22 | CHI | C | 31 | 73 | 33.1 | 18.2 | 53.3 | 51.8 | 24.4 | 15.3 | 16.8 | 6.0 | 27.4 | 8.6 | 111.3 | 112.8 | -1.6 | 99.0 | 13.2 | 5,000 | |
| 2022-23 | CHI | C | 32 | 82 | 33.5 | 19.2 | 59.4 | 57.3 | 21.8 | 14.6 | 17.2 | 6.2 | 27.4 | 8.6 | 112.3 | 112.8 | -0.5 | 99.3 | 14.3 | 5,686 | |
| 2023-24 | CHI | C | 33 | 76 | 34.3 | 17.7 | 54.0 | 52.2 | 23.3 | 15.3 | 15.4 | 8.0 | 22.9 | 7.3 | 112.5 | 115.7 | -3.1 | 97.4 | 12.6 | 5,287 | |
| 2024-25 | CHI | C | 34 | 73 | 31.2 | 20.4 | 61.1 | 59.2 | 22.1 | 16.5 | 15.4 | 7.6 | 22.8 | 8.1 | 113.6 | 116.0 | -2.4 | 104.1 | 13.6 | 4,950 | |
| 2025-26 | CHI/BOS | C | 35 | 64 | 28.4 | 17.7 | 57.4 | 55.6 | 21.3 | 17.5 | 14.1 | 6.7 | 21.1 | 7.4 | 113.1 | 114.8 | -1.7 | 102.0 | 12.7 | 3,874 |